Chemkart India Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹3(1.21%)
Premium (ELP)
The public market debut of Chemkart India Limited's was completed on Jul 14, 2025 with its listing on the BSE exchange. The IPO process raised 32,29,200 Shares in total capital, consisting of 26,00,000 Shares in new equity and ₹15.60 Cr in existing share sales through the OFS route.
The offering featured a price range of ₹236 to ₹248 and minimum application size of 600 shares. Investor response during the subscription period from Jul 07, 2025 to Jul 09, 2025 influenced the final allotment ratios across investor categories.
Final allotment was announced on Jul 10, 2025, distributing shares to successful subscribers. The listing established a continuous market for the company's shares, enabling liquidity, valuation transparency, and broader investor participation.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Chemkart India Limited, established in 2015, is a distributor that supplies high-quality food and health ingredients. It connects global ingredient manufacturers with businesses across different industries through a B2B model. The company mainly serves manufacturers of supplements such as sports nutrition, health products, vitamins, and protein-based items. It focuses on offering a wide range of products that are affordable and of good quality, while maintaining strong customer relationships and improving supply chain efficiency. Chemkart also provides grinding, blending, and packaging services at its clean and well-maintained facility located in Bhiwandi, Mumbai. The warehouse, spread over 28,259.16 square feet, is designed to handle processing, labeling, and sealing tasks efficiently. The company’s product range includes amino acids, health supplements, herbal extracts, nucleotides, proteins, sports nutrition ingredients, and vitamins — all playing key roles in health, fitness, and overall well-being. As of March 31, 2025, Chemkart employed 40 people.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Broad and diverse product portfolio covering seven major nutraceutical categories like amino acids, proteins, vitamins, and herbal extracts to serve varied customer needs.
- In-house processing and warehousing facility in Bhiwandi enables hygienic blending, grinding, packaging, and labeling with support from skilled staff and contract experts.
- Strong B2B customer relationships focused on long-term partnerships, ensuring high retention and sustainable growth in the nutraceutical sector.
- No exclusive supplier agreements may affect raw material consistency during demand surges or shortages.
- High working capital dependency due to large inventory needs can strain finances during slow sales periods.
- Reliance on key personnel for critical operations poses a risk if any key member exits the company.
- Mr. Ankit Shaileesh Mehta
- Ms. Parul Shaileesh Mehta
- Mr. Shaileesh Vinodrai Mehta
Chemkart India Limited
Bigshare Services Private Limited